Treatment of acute coronary syndromes in patients with type 2 diabetes mellitus with β-adrenoblockers and angiotensin-converting enzyme inhibitors: cardiohemodynamic effects and impact for prognosis

Author: Ivanova L.   Kanorskii S.   Rostovtseva O.   Sufian Basit   Galenko-Yaroshevskii P.  

Publisher: Springer Publishing Company

ISSN: 0007-4888

Source: Bulletin of Experimental Biology and Medicine, Vol.138, Iss.3, 2004-09, pp. : 301-304

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Long-term oral treatment of patients with acute coronary syndromes and type 2 diabetes mellitus with β-adrenoblockers and angiotensin-converting enzyme inhibitors is associated with positive, though ambiguous changes in the left-ventricular structure and function. These changes should be the reason for choosing optimal therapy ensuring better prognosis in this patient population.

Related content